Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × INDIV × 1 year × Clear all

Phase

Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 143 INDUSTRY 122 NIH 18 OTHER_GOV 6 NETWORK 4 INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡